{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:45Z","timestamp":1786982145820,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11926-012-0283-1","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T04:56:23Z","timestamp":1344401783000},"page":"532-538","source":"Crossref","is-referenced-by-count":38,"title":["Cocaine-Induced Vasculitis: Clinical and Immunological Spectrum"],"prefix":"10.1007","volume":"14","author":[{"given":"Luis R.","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Perez Alamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"283_CR1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1139\/y89-187","volume":"67","author":"T Paolo Di","year":"1989","unstructured":"Di Paolo T, Rouillard C, Morissette M, Levesque D, Bedard PJ. Endocrine and neurochemical actions of cocaine. Can J Physiol Pharmacol. 1989;67:1177\u201381.","journal-title":"Can J Physiol Pharmacol"},{"key":"283_CR2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","volume":"369","author":"D Nutt","year":"2007","unstructured":"Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369:1047\u201353.","journal-title":"Lancet"},{"key":"283_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1067\/moe.2002.126020","volume":"94","author":"BA Seyer","year":"2002","unstructured":"Seyer BA, Grist W, Muller S. Aggressive destructive midfacial lesion from cocaine abuse. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:465\u201370.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"283_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1590\/S0482-50042012000300012","volume":"52","author":"L Stahelin","year":"2012","unstructured":"\u2022 Stahelin L, Fialho SC, Neves FS, Junckes L, de Castro GR W, Pereira IA. Cocaine-induced midline destruction lesions with positive ANCA test mimicking Wegener\u2019s granulomatosis. Rev Bras Reumatol. 2012;52:434\u20137. Interesting case report and literature review about cocaine-induced midline lesions mimicking Wegener\u2019s granulomatosis.","journal-title":"Rev Bras Reumatol"},{"key":"283_CR5","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.20479","volume":"50","author":"O Wiesner","year":"2004","unstructured":"Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004;50:2954\u201365.","journal-title":"Arthritis Rheum"},{"key":"283_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jaad.2008.03.040","volume":"59","author":"JD Brewer","year":"2008","unstructured":"Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008;59:483\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"283_CR7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000018500","volume":"201","author":"GF Hofbauer","year":"2000","unstructured":"Hofbauer GF, Burg G, Nestle FO. Cocaine-related Stevens\u2013Johnson syndrome. Dermatology. 2000;201:258\u201360.","journal-title":"Dermatology"},{"key":"283_CR8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0002-9343(89)80401-2","volume":"87","author":"NA Ettinger","year":"1989","unstructured":"Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med. 1989;87:664\u20138.","journal-title":"Am J Med"},{"key":"283_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03256408","volume":"15","author":"PA Wijnen","year":"2011","unstructured":"Wijnen PA, Bekers O, Drent M. Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers. Mol Diagn Ther. 2011;15:177\u201380.","journal-title":"Mol Diagn Ther"},{"key":"283_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03256574","volume":"9","author":"K Phillips","year":"2009","unstructured":"Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9:177\u201396.","journal-title":"Am J Cardiovasc Drugs"},{"key":"283_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0272-6386(00)70246-0","volume":"35","author":"CM Nzerue","year":"2000","unstructured":"Nzerue CM, Hewan-Lowe K, Riley Jr LJ. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am J Kidney Dis. 2000;35:783\u201395.","journal-title":"Am J Kidney Dis"},{"key":"283_CR12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5414\/CNP68182","volume":"68","author":"AE Sirvent","year":"2007","unstructured":"Sirvent AE, Enriquez R, Andrada E, Amoros F, Gallego JA, Gonzalez C, et al. Goodpasture\u2019s syndrome in a patient using cocaine\u2014a case report and review of the literature. Clin Nephrol. 2007;68:182\u20135.","journal-title":"Clin Nephrol"},{"key":"283_CR13","first-page":"30","volume":"16","author":"F Fabbian","year":"2012","unstructured":"Fabbian F, Pala M, De Giorgi A, et al. Left kidney: an unusual site of cocaine-related renal infarction. A case report. Eur Rev Med Pharmacol Sci. 2012;16:30\u20133.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"283_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/pgmj.2006.055970","volume":"83","author":"SD Treadwell","year":"2007","unstructured":"Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J. 2007;83:389\u201394.","journal-title":"Postgrad Med J"},{"key":"283_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0049-0172(95)80029-8","volume":"25","author":"PA Merkel","year":"1995","unstructured":"Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum. 1995;25:172\u201383.","journal-title":"Semin Arthritis Rheum"},{"key":"283_CR16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.46.5.1291","volume":"46","author":"KB Nolte","year":"1996","unstructured":"Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996;46:1291\u20136.","journal-title":"Neurology"},{"key":"283_CR17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/WNL.46.6.1741","volume":"46","author":"SK Aggarwal","year":"1996","unstructured":"Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology. 1996;46:1741\u20133.","journal-title":"Neurology"},{"key":"283_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2003.09.056","volume":"482","author":"J Su","year":"2003","unstructured":"Su J, Li J, Li W, Altura BT, Altura BM. Cocaine induces apoptosis in cerebral vascular muscle cells: potential roles in strokes and brain damage. Eur J Pharmacol. 2003;482:61\u20136.","journal-title":"Eur J Pharmacol"},{"key":"283_CR19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ncpneuro0918","volume":"4","author":"JS Han","year":"2008","unstructured":"Han JS, Mandell DM, Poublanc J, Mardimae A, et al. BOLD-MRI cerebrovascular reactivity findings in cocaine-induced cerebral vasculitis. Nat Clin Pract Neurol. 2008;4:628\u201332.","journal-title":"Nat Clin Pract Neurol"},{"key":"283_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.02.017","volume":"20","author":"P Bhattacharya","year":"2011","unstructured":"Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20:443\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"283_CR21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuro.2011.03.005","volume":"32","author":"F Bianco","year":"2011","unstructured":"Bianco F, Iacovelli E, Tinelli E, Lepre C, Pauri F. recurrent leukoencephalopathy in a cocaine abuser. Neurotoxicology. 2011;32:410\u20132.","journal-title":"Neurotoxicology"},{"key":"283_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.96.09010175","volume":"9","author":"R Orriols","year":"1996","unstructured":"Orriols R, Munoz X, Ferrer J, Huget P, Morell F. Cocaine-induced Churg\u2013Strauss vasculitis. Eur Respir J. 1996;9:175\u20137.","journal-title":"Eur Respir J"},{"key":"283_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1345\/aph.1L487","volume":"43","author":"SC Chen","year":"2009","unstructured":"Chen SC, Jang MY, Wang CS, Tsai KB, et al. Cocaine-related vasculitis causing scrotal gangrene. Ann Pharmacother. 2009;43:375\u20138.","journal-title":"Ann Pharmacother"},{"key":"283_CR24","first-page":"1381","volume":"18","author":"Centers for Disease Control and Prevention","year":"2009","unstructured":"\u2022\u2022 Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use\u2014four States, March 2008\u2013November 2009. MMWR Morb Mortal Wkly Rep. 2009;18:1381\u20135. Initial report describing agranulocytosis associated with levamisole-contaminated cocaine use.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"283_CR25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1309\/AJCPOPQNBP5THKP1","volume":"133","author":"DR Czuchlewski","year":"2010","unstructured":"Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133:466\u201372.","journal-title":"Am J Clin Pathol"},{"key":"283_CR26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/cncr.24969","volume":"116","author":"B Ejlertsen","year":"2010","unstructured":"Ejlertsen B, Mouridsen HT, Jensen MB, et al. Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer. Cancer. 2010;116:2081\u20139.","journal-title":"Cancer"},{"key":"283_CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/ecp.10.31","volume":"3","author":"J Oh","year":"2010","unstructured":"Oh J, Kemper MJ. Second-line options for refractory steroid-sensitive and \u2013resistant nephritic syndrome. Expert Rev Clin Pharmacol. 2010;3:527\u201337.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"283_CR28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/anatox\/35.3.176","volume":"35","author":"KL Lynch","year":"2011","unstructured":"Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography\u2013tandem mass spectrometry. J Anal Toxicol. 2011;35:176\u20138.","journal-title":"J Anal Toxicol"},{"key":"283_CR29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bmj.1.6110.407","volume":"18","author":"DG Macfarlane","year":"1978","unstructured":"Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J. 1978;18:407\u20138.","journal-title":"Br Med J"},{"key":"283_CR30","first-page":"1721","volume":"62","author":"J Symoens","year":"1978","unstructured":"Symoens J, Veys E, Mielans M, Pinals R. Adverse reactions to levamisole. Cancer Treat Rep. 1978;62:1721\u201330.","journal-title":"Cancer Treat Rep"},{"key":"283_CR31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.37.4.366","volume":"37","author":"GT Williams","year":"1978","unstructured":"Williams GT, Johnson SAN, Dieppe PA, Huskisson EC. Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis. 1978;37:366\u20139.","journal-title":"Ann Rheum Dis"},{"key":"283_CR32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.156","volume":"88","author":"A Chang","year":"2010","unstructured":"Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88:408\u201311.","journal-title":"Clin Pharmacol Ther"},{"key":"283_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/15563650.2012.665455","volume":"50","author":"A Larocque","year":"2012","unstructured":"Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012;50:231\u201341.","journal-title":"Clin Toxicol"},{"key":"283_CR34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1553-2712.2011.01202.x","volume":"18","author":"PR Chai","year":"2011","unstructured":"Chai PR, Bastan W, Machan J, Hack JB, Babu KM. Levamisole exposure and hematologic indices in cocaine users. Acad Emerg Med. 2011;18:1141\u20137.","journal-title":"Acad Emerg Med"},{"key":"283_CR35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.semarthrit.2011.05.009","volume":"41","author":"SH Poon","year":"2011","unstructured":"\u2022\u2022 Poon SH, Baliog Jr CR, Sams RN, et al. Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum. 2011;41:434\u201344. Complete description of clinical and hematological manifestations associated with levamisole-contaminated cocaine use.","journal-title":"Semin Arthritis Rheum"},{"key":"283_CR36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.semarthrit.2011.04.010","volume":"41","author":"TA Khan","year":"2011","unstructured":"\u2022\u2022 Khan TA, Cuchacovich R, Espinoza LR, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum. 2011;41:445\u201354. Comprehensive report with complete literature review of clinical and laboratory manifestations associated with levamisole-contaminated cocaine use.","journal-title":"Semin Arthritis Rheum"},{"key":"283_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MOH.0b013e32834da9ef","volume":"19","author":"JA Buchanan","year":"2012","unstructured":"Buchanan JA, Lavonas EJ. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol. 2012;19:27\u201331.","journal-title":"Curr Opin Hematol"},{"key":"283_CR38","first-page":"226","volume":"66","author":"S Perkisas","year":"2011","unstructured":"Perkisas S, Vrelust I, Martin M, Gadisseur A, Schroyens W. A warning about agranulocytosis with the use of cocaine adulterated with levamisole. Acta Clin Belg. 2011;66:226\u20137.","journal-title":"Acta Clin Belg"},{"key":"283_CR39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/dmd.112.045021","volume":"40","author":"A Wolford","year":"2012","unstructured":"Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012;40:1067\u201375.","journal-title":"Drug Metab Dispos"},{"key":"283_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BCR.0b013e318233fc64","volume":"33","author":"JA Ching","year":"2012","unstructured":"Ching JA, Smith Jr DJ. Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res. 2012;33:1\u20135.","journal-title":"J Burn Care Res"},{"key":"283_CR41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/PHAR.1012","volume":"32","author":"CW Freyer","year":"2012","unstructured":"Freyer CW, Peters M. Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: a case of levamisole and cocaine coingestion. Pharmacotherapy. 2012;32:17\u201323.","journal-title":"Pharmacotherapy"},{"key":"283_CR42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/DAD.0b013e31821cc0bf","volume":"34","author":"RS Jacobs","year":"2012","unstructured":"Jacobs RS, Silva CY, Powers JG, et al. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012;34:208\u201313.","journal-title":"Am J Dermatopathol"},{"key":"283_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","volume":"17","author":"K Ullrich","year":"2011","unstructured":"Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol. 2011;17:193\u20136.","journal-title":"J Clin Rheumatol"},{"key":"283_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/RHU.0b013e31821cb9d5","volume":"17","author":"NA Zwang","year":"2011","unstructured":"Zwang NA, Van Wagner LB, Rose S. A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol. 2011;17:197\u2013200.","journal-title":"J Clin Rheumatol"},{"key":"283_CR45","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/BCR.0b013e318235615a","volume":"33","author":"RW Farmer","year":"2012","unstructured":"Farmer RW, Malhotra PS, Mays MP, et al. Necrotizing peripheral vasculitis\/vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res. 2012;33:e6\u201311.","journal-title":"J Burn Care Res"},{"key":"283_CR46","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/art.30590","volume":"63","author":"J Graf","year":"2011","unstructured":"\u2022 Graf J, Lynch K, Yeh CL, et al. Purpura, cutaneous necrosis, and anti-neutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum. 2011;63:3998\u20134001. Very good description of the dermatological and autoimmune manifestations associated with the use of levamisole-contaminated cocaine.","journal-title":"Arthritis Rheum"},{"key":"283_CR47","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2215\/CJN.03440411","volume":"6","author":"MM McGrath","year":"2011","unstructured":"McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6:2799\u2013805.","journal-title":"Clin J Am Soc Nephrol"},{"key":"283_CR48","doi-asserted-by":"crossref","unstructured":"Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012;23 [Epub ahead of print].","DOI":"10.1007\/s11239-012-0711-0"},{"key":"283_CR49","unstructured":"Friend K, Milone MC, Perrone J. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients. Ann Emerg Med. 2011;Sep 27 [Epub ahead of print]."},{"key":"283_CR50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.mayocp.2012.03.010","volume":"87","author":"KC Lee","year":"2012","unstructured":"\u2022\u2022 Lee KC, Ladizinski B, Federman DG. Complications associated with the use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87:581\u20136. Excellent review of the subject.","journal-title":"Mayo Clin Proc"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0283-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-012-0283-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0283-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:36:00Z","timestamp":1714275360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-012-0283-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1007\/s11926-012-0283-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}